![Hans Lennernäs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Lennernäs
Founder at Canthera AB
Hans Lennernäs active positions
Companies | Position | Start | End |
---|---|---|---|
Recipharm Pharmaceutical Development AB | Director/Board Member | - | - |
Hans Lennernäs Biomedical AB
![]() Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Hans Lennernäs Biomedical AB is a private company based in Uppsala, Sweden. The Swedish company provides medical research, development, and teaching services. Additionally, they own and manage real estate. | Director/Board Member | - | - |
Canthera AB
![]() Canthera AB Pharmaceuticals: MajorHealth Technology Canthera AB is a Swedish company that develops, manufactures, and wholesales pharmaceuticals and medical equipment. The private company is based in Uddevalla, Sweden. The company was founded by Hans Lennernäs. | Director/Board Member | - | - |
Founder | - | - |
Career history of Hans Lennernäs
Former positions of Hans Lennernäs
Companies | Position | Start | End |
---|---|---|---|
University of Uppsala | Corporate Officer/Principal | - | - |
DuoCort Pharma AB
![]() DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Founder | - | - |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Director/Board Member | - | - |
Founder | - | - | |
NANOLOGICA AB | Director/Board Member | 31/12/2013 | - |
Independent Dir/Board Member | 31/12/2013 | - | |
LIDDS AB | Director/Board Member | 22/02/2010 | - |
Founder | 31/12/2002 | - | |
Corporate Officer/Principal | 29/06/2011 | - |
Training of Hans Lennernäs
University of Uppsala | Doctorate Degree |
Statistics
International
Sweden | 9 |
Operational
Director/Board Member | 6 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
LIDDS AB | Health Technology |
NANOLOGICA AB | Health Technology |
Private companies | 5 |
---|---|
Recipharm Pharmaceutical Development AB | Health Technology |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Health Technology |
Hans Lennernäs Biomedical AB
![]() Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Hans Lennernäs Biomedical AB is a private company based in Uppsala, Sweden. The Swedish company provides medical research, development, and teaching services. Additionally, they own and manage real estate. | Commercial Services |
DuoCort Pharma AB
![]() DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
Canthera AB
![]() Canthera AB Pharmaceuticals: MajorHealth Technology Canthera AB is a Swedish company that develops, manufactures, and wholesales pharmaceuticals and medical equipment. The private company is based in Uddevalla, Sweden. The company was founded by Hans Lennernäs. | Health Technology |
- Stock Market
- Insiders
- Hans Lennernäs
- Experience